The clickable links below navigate directly to outside media articles which featured Department of Medicine faculty and staff throughout the month of June 2025.
David Wohl, MD, had a video interview on injectable PrEP.
Sarah McGill, MD, spoke about alpha-gal syndromes’ effect on the digestive system.
Onyinye I. Iweala, MD, PhD, did a Q&A on managing care for patients with insulin allergy.
Jared Weiss, MD, was interviewed by Cure on novel research in lung cancer.
Samuel Rubinstein, MD, unpacked the findings of his KarMMa-3 trial of idecabtagene vicleucel in CAR T-cell therapy.
Spencer Dorn, MD, MPH, wrote an article on AI agents integration into healthcare.
Joshua Zeidner, MD, was a corresponding author on a study on a novel AML drug and will be the lead US investigator for its clinical trial.
Trevor Barlowe, MD, and Sarah McGill, MD, found that a newly approved treatment for C. Diff. has a harmful impact on infection rebound.
Christopher Dittus, DO, MPH, participated in a study testing an effective new treatment for a rare form of leukemia.
David Wohl, MD, addressed the recent measles resurgence and emphasized the importance of community-wide vaccination efforts.
Samuel Rubinstein, MD, analyzed how BCMA expression and bridging therapy influence ide-cel outcomes in multiple myeloma.
A. Sidney Barritt IV, MD, highlighted the critical need for early intervention in patients with noncirrhotic MASH and fibrosis.
Andrew Moon, MD, MPH, advocated for a holistic approach to managing metabolic dysfunction-associated steatohepatitis in a recent Q&A.
Amanda Nelson, MD, MSCR, spoke about her osteoarthritis research involving humans and dogs.
Ross Boyce, MD, discussed the growing risk of Lyme disease in North Carolina and practical prevention strategies.
M. Bradley Drummond, M.D., MHS, lead a study showing digital inhalers may help predict COPD flare-ups.
John Buse, MD, PhD, co published a study that found improved glycemia with Mifepristone treatment in type 2 diabetes.